Table 3

Changes from baseline to follow-up in cardiometabolic risk factors according to self-reported changes in physical activity during follow-up

VariableNo increase in physical activityIncrease in physical activityp Value*p Valuep Valuep Value§p Valuep Value**
nMean (SD)nMean (SD)
Weight, kg1380−0.67 (5.20)310−4.27 (7.03)<0.001<0.001<0.001<0.001<0.001
BMI, kg/m21373−0.26 (1.73)310−1.53 (2.56)<0.001<0.0010.326<0.001<0.001<0.001
Waist, cm1343−0.71 (5.31)301−4.30 (6.59)<0.001<0.001<0.001<0.001<0.001
Systolic BP, mm Hg1367−1.21 (14.32)308−3.24 (14.17)0.0270.0430.1990.0610.0640.197
Diastolic BP, mm Hg1367−1.27 (8.58)308−2.93 (8.10)0.0020.0030.0590.0150.0080.013
Total cholesterol, mmol/l1264−0.15 (0.83)283−0.32 (0.85)0.0020.0050.0280.0100.0010.005
HDL cholesterol, mmol/l12560.02 (0.29)2830.07 (0.30)0.0140.0820.2020.0990.0640.028
LDL cholesterol, mmol/l1231−0.17 (0.75)278−0.33 (0.76)0.0010.0040.0080.0050.0010.012
LDL/HDL ratio1231−0.17 (0.69)278−0.33 (0.66)<0.0010.002<0.0010.0070.0010.001
Triglycerides, mmol/l1253−0.02 (0.80)282−0.12 (0.69)0.0680.1020.7190.2660.0850.007
Fasting glucose, mmol/l1380-0.02 (0.49)310−0.11 (0.48)0.0040.0210.1020.0780.0270.011
2 h glucose, mmol/l1378−0.20 (1.53)309−0.56 (1.56)0.0230.0040.0160.0310.0020.001
  • * p Values for difference between those who did not increase versus increased physical activity during follow-up adjusted for sex and age at baseline (analysis of variance).

  • p Values adjusted for sex and age at baseline and dietary change.

  • p Values adjusted for sex and age at baseline and change in weight during follow-up.

  • § p Values adjusted for sex and age at baseline and change in waist circumference during follow-up.

  • p Values adjusted for sex and age at baseline and number of intervention visits.

  • ** p Values adjusted for sex and age at baseline and baseline values.

  • BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.